期刊文献+

3项指标联合检测在2型糖尿病早期肾损害的诊断价值 被引量:11

Diagnostic value of combined measurement of serum Hcy,serum Cys C,urinary microalbumin and urinary creatinine ratio levels in type 2 diabetes mellitus with early kidney injury
下载PDF
导出
摘要 目的探讨联合检测同型半胱氨酸(Hcy)、血清胱抑素C(Cys C)和尿微量清蛋白(UmAlb)与尿肌酐(UCr)比值在2型糖尿病(T2DM)肾损害早期诊断和治疗意义。方法依据24h尿微量白蛋白的定量测结果将182例T2DM患者分为3组:A组为糖尿病无肾病组(UmAlb<30mg/24h)60例,B组为早期糖尿病肾病组(EDN)(UmAlb≧30mg~300mg/24h)62例,C组为糖尿病明显肾病组(ADN)(UmAlb>300mg/24h)60例。对这3组患者进行血清Cys C、Hcy、UmAlb/UCr、血肌酐(SCr)、血尿素氮(BUN)含量检测,并与50例健康对照组进行比较。结果 B组CysC、Hcy、UmAlb/UCr水平分别为(1.95±0.52)mg/L、(17.18±2.57)μmol/L、(142.5±31.47)mg/g,C组分别为(2.43±0.65)mg/L、(19.28±3.66)μmol/L、(387.2±61.48)mg/g,均高于健康对照组和A组,差异有统计学意义(P<0.05);C组血清Cys C、血清Hcy、UmAlb/UCr水平高于B组,差异有统计学意义(P<0.05);以单一指标阳性作为诊断标准,血清Cys C、血清Hcy、UmAlb/UCr对2型糖尿病肾损害的阳性率分别为85.2%、80.3%、86.9%,3项联合检测阳性率达96.7%,明显高于单项检测(P<0.05)。结论联合检测血清Hcy、血清Cys C、UmAlb/UCr对2型糖尿病肾病早期诊断及病情监测具有重要价值。 Objective To explore the diagnostic value of combined measurement of serum homocysteine (Hcy),serum cystatin C(Cys C), urinary microalbumin(UmAlb) and urinary creatinine(UCr) ratio levels in type 2 diabetes mellitus with early kidney injury. Methods 182 cases of type 2 diabetes mellitus(T2DM)patients were en- rolled and divided into three groups according to the excretion rate 24 hour urinary microalbumin. A group without diabetic nephropathy(UmAlb^30 mg/24 h)(NDN,60cases), g group with early diabetes nephropathy(30 rag/24 h UmAlb ≤ 300 mg/24 h (EDN, 62 cases), C group with apparent diabetic nephropathy (UmAlb 〉300 mg/24 h (ADN,60 cases), and 50 healthy people served as normal control group(D group). Serum Cys C, Serum homocysteine, urinary microalbumin, urinary creatinine, serum creatinine and blood urea nitrogen of these four groups were de- tected simultaneously. Results Levels of serum Hcy, serum Cys C, UmAlb/UCr ratio in these two groups(B, C group)were higher than D group, Serum Hey, serum Cys C, UmAlb/UCr ratio were significantly different between group B, C and group D(P〈0.05). Levels of serum H cy, serum Cys C, UmAlb/UCr ratio in these two groups(B, C) were higher than A group. Serum Hcy, serum Cys C, UmAlb/UCr ratio were significantly different between group B, C and group A(P〈0.05). Levels of serum Hcy,serum Cys C,UmAlb/UCr ratio in the group C were higher than group B. Serum Hcy,serum Cys C,UmAlb/UCr ratio were significantly different between group C and group B(P〈 0.05). As a single positive marker for diagnosis, the sensitivity for serum CysC, serum Hcy, and UmAlb/UCr were 85.2%, 80.3 % and 86.9% respectively, the positive rate of combined detection was 96.7%, which was significantly higher than that of the individual testing(P〈0.05). Conclusion Combined measurement of serum Hcy,serum Cys C,and UmAIb/UCr ratio levels has important clinical value for diagnosis and condition monitoring in type 2 diabetes mellitus with early kidney injury.
出处 《检验医学与临床》 CAS 2012年第18期2315-2317,共3页 Laboratory Medicine and Clinic
关键词 2型糖尿病 早期肾损害 胱抑素C 同型半胱氨酸 尿微量白蛋白 尿肌酐 type 2 diabetes mellitus early kidney injury cystatin C homocysteine urinary mi- croalbumin urinary creatinine
  • 相关文献

参考文献14

  • 1谢少武,李国娟.2型糖尿病早期肾损伤中血清胱抑素C的测定[J].实用医学杂志,2009,25(18):3091-3092. 被引量:4
  • 2Kelly PJ, Rosand J, Kistler JP, et al. Homocysteine, MTHFR 677C->T polymorphism,and risk of isehemic stroke: results of a meta-analysis[J]. Neurology, 2002, 59(4) :529-536.
  • 3Wald DS, Law M, Morris JK. Homocysteine and cardio vascular disease:evidence on causality from a meta-analy sis[J]. BMJ, 2002,325 (7374) : 1202.
  • 4Lazzerini PE,Capecchi PL,Selvi E,et al. Hyperhomocys- teinemia : a cardiovascular risk factor in autoimmune disea- ses? [J].Lupus,2007,16(11):852--862.
  • 5Hillenbrand R, Hillenbrand A, I.iewld F, et al. Hyperho mocysteinemia and recurrent carotid stenosis [J]. BMC Cardiovase Disord, 2008,8 ( 1 ) : 1-2.
  • 6Ozemen B, Ozemen D, Turgan N, et al. Association be- tween homocysteinemia and real function in patients with type 2 cliabetes mellitus[J]. Ann Clin Lab Sci, 2002,32 (2) :279-286.
  • 7Lentz SR. Homocysteine and cardiovascular physiology [M]. Cambridge: University Press,2001:441-450.
  • 8Hucks D, Thuraisingham RC, RMtery MJ, et al. Homo cysteine induced impairment of nitric oxide-dependent va- sorelaxation is reversible by the superoxide dismutase mi metic TEMPOL [J]. Nephrol Dial Transplant, 2004, 19 (8) :1999-2005.
  • 9刘军须,张敬各,王树人.同型半胱氨酸对内皮细胞一氧化氮合酶活力及基因表达的影响[J].华西药学杂志,2007,22(5):508-511. 被引量:19
  • 10杨天崙,贺琳,李传昶,蒲晓群,郑昭芬,邓金华,孟双媛.冠心病患者血清同型半胱氨酸与冠脉侧支循环的关系[J].中南大学学报(医学版),2006,31(5):655-658. 被引量:8

二级参考文献27

  • 1Randers E, Erlandsen E J. Serum systatin C as an endogenous marker of the renal function a review [J]. Clin Chem Lab Med, 1999,37 (4) : 389-395.
  • 2Laterza D F, Price C P, Scott M G. Cystatin C: An improved estimator of glomerular filtration rate [J]. Ctin Chem, 2002,48(5) : 699-707.
  • 3Lim U,Cassano P A,et al.Homocysteine and blood pressure in the third national health and nutrition examination survey,1988-1994[J].Am J Epidemiol,2002,156(12):1105-1113.
  • 4Soinio M,Marniemi J,Laakso M,et al.Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with Type 2 diabetes mellitus[J].Ann Int Med,2004,140(2):94-100.
  • 5Hassan A,Hunt BJ,O'Sullivan M,et al.Homocysteine is a risk factor for cerebral small vessel disease,acting via endothelial dysfunction[J].Brain,2004,127(1):212-219.
  • 6Woo K S,Chook P,Lolin Y I,et al.Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans[J].Circulation,1997,95(12):2542-2544.
  • 7Duan J,Murohara T,Ikeda H,et al.Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia[J].Arterioscler,Thromb Vasc Biol,2000,20(12):2579-2585.
  • 8Nagai Y,Tasaki H,Miyamoto M,et al.Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease[J].Circ J,2002,66(2):158-162.
  • 9Rentrop K P,Cohen M,Blanke H,et al.Changes in colla-teral channel filling immediately after control coronary artery occlusion by an angioplasty balloon in human subjects[J].J Am Coll Cardiol,1985,5(3):587-592.
  • 10Gensini G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606-609.

共引文献31

同被引文献89

引证文献11

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部